A. Giles

Statistics

Publications

Citations

H-Index

Active since

1993

Affiliations

Oxford Instruments (United Kingdom)(Current)

MSD (UK) Limited (United Kingdom)

Merck & Co., Inc., Rahway, NJ, USA (United States)

A. Giles is an author at Oxford Instruments (United Kingdom) specializing in inflammatory bowel disease, cardiovascular disease prevalence, and inflammatory bowel disease therapy.

Publications per year

1993–2023

Publications

Prevalence and management of chronic kidney disease in primary care patients in the UK

K. Jameson, Susan S. Jick, Katrina Wilcox Hagberg et al. · International Journal of Clinical Practice · 2014 · 35 citations

Medicine, Internal Medicine, Nephrology +14

A <scp>UK</scp> retrospective observational study of clinical outcomes and healthcare resource utilisation of infliximab treatment in Crohn's disease

James O. Lindsay, R. Chipperfield, A. Giles et al. · Alimentary Pharmacology & Therapeutics · 2013 · 23 citations

Pharmacy, Pharmacoeconomics, Surgery +17

Increasing frailty is associated with higher prevalence and reduced recognition of delirium in older hospitalised inpatients: results of a multi-centre study

Waleed Faheem, Taran Nandra, Sarah Richardson et al. · European Geriatric Medicine · 2023 · 15 citations · Full text

Medicine, Geriatric Medicine, Psychiatry +17

Impact of lipid‐lowering therapy on the prevalence of dyslipidaemia in patients at high‐risk of cardiovascular events in <scp>UK</scp> primary care – a retrospective database study

K. Jameson, Vian Amber, K. D’Oca et al. · International Journal of Clinical Practice · 2013 · 12 citations · Full text

Medicine, Pharmacotherapy, Clinical Epidemiology +13

Does Exclusion of Enteral Lipid Assist Remission in Crohnʼs Disease?

W. E. W. Roediger, A. Giles, A. Kaczmar et al. · Journal of Clinical Gastroenterology · 1993 · 11 citations

Life Sciences, Nutrition, Nutritional Sciences +17

1–5 of 5